School of Medicine


Showing 11-20 of 23 Results

  • Erik Ingelsson

    Erik Ingelsson

    Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Health Research and Policy (Epidemiology)

    Current Research and Scholarly Interests We are interested in the link between metabolic disturbances, such as obesity and insulin resistance, and the development of cardiovascular disease. Our research is translational and interdisciplinary, combining population-based studies with molecular biology to reach new insights into the pathophysiology of cardiovascular disease and related conditions, identification of new biomarkers for improved risk prediction, and discovery of novel drug targets.

  • John P.A. Ioannidis

    John P.A. Ioannidis

    C. F. Rehnborg Professor in Disease Prevention in the School of Medicine, Professor of Medicine, of Health Research and Policy (Epidemiology) and by courtesy, of Statistics and of Biomedical Data Science

    Current Research and Scholarly Interests Meta-research
    Evidence-based medicine
    Clinical and molecular epidemiology
    Human genome epidemiology
    Research design
    Reporting of research
    Empirical evaluation of bias in research
    Randomized trials
    Statistical methods and modeling
    Meta-analysis and large-scale evidence
    Prognosis, predictive, personalized, precision medicine and health
    Sociology of science

  • Eric Ip

    Eric Ip

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    Bio Dr. Ip is Director of Clinical Therapeutics Curriculum for the Stanford University MSPA Program and Clinical Associate Professor in the Department of Medicine, Division of Primary Care and Population Health. He completed his Doctor of Pharmacy degree from UCSF School of Pharmacy and his post-graduate residency at Kaiser Permanente Santa Clara Medical Center. He is a clinical pharmacist specializing in diabetes and cardiovascular care. He established and currently co-leads the Diabetes Management Program at Kaiser Permanente Mountain View Medical Offices. He is also Chair and Professor of Clinical Sciences at Touro University California College of Pharmacy. Dr. Ip's research interests include anabolic steroids and performancing enhancing drugs as well as educational research.

  • Steven S Isono

    Steven S Isono

    Clinical Professor, Orthopaedic Surgery

    Bio Steven S. Isono, M.D. is a Board Certified Orthopaedic Surgeon who specializes in Sports Medicine as well as surgery of the knee and the shoulder.
    He attended Harvard University in Cambridge, Massachusetts concentrating in Biochemical Sciences and wrote a Thesis on Sickle Cell Anemia. He then attended medical school at Northwestern University in Chicago, Illinois, continued research investigating Liver Hepatomas and received his M.D. degree in 1982. The next five years included studying Microsurgery in Japan at the Kyoto University Hospital and the Tokyo Metropolitan Hospital as well as completing both his Internship in General Surgery and Residency in Orthopedic Surgery at the Stanford University Medical Center in 1987.

    Dr. Isono received his initial Board Certification in Orthopaedic Surgery in 1989 and has been re-certified in 1999, 2009 and 2018. Steve also received a Certificate of Added Qualification (CAQ) in Sports Medicine in the inaugural class of 2007 and was re-certified in 2017. He is a member of many professional societies including the Association of NBA Team Physicians, The Olympic Sports Medicine Society, the American Academy of Orthopaedic Surgeons, The American Board of Orthopaedic Surgery, the American Orthopaedic Society of Sports Medicine, the Arthroscopy Association of North America, the California Orthopaedic Association, the Western Orthopaedic Association, and the American College of Sports Medicine,

    Steve is currently serving as a Team Physician for the Golden State Warriors of the National Basketball Association, United States Olympic Committee (USA Men's Swimming, Triathlon, Judo, Taekwondo, and Track and Field, Rowing and Boxing), and for Laney College. He is also a Consultant for the Ironman World Triathlon Championships, the Dew Tour of Action Sports, and the Association of Volleyball Professionals. Steve has also served as a Team Physician for the World Games of the Special Olympics, the 2015 Pan American Games in Toronto, Canada, the XXXI Olympic Games in Rio de Janeiro, Brazil in 2016, the Youth Olympic Games in Buenos Aries, Argentina in 2018, and will be attending the 2019 Pan American Games in Lima, Peru.

  • Haruka Itakura

    Haruka Itakura

    Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center

    Bio I am an Assistant Professor of Medicine (Oncology) in the Stanford University School of Medicine. As a physician-scientist, my research mission is to drive medical advances at the intersection of cancer and data science research. Specifically, I aim to innovate state-of-the-art technologies to extract clinically useful knowledge from heterogeneous multi-scale biomedical data to improve diagnostics and therapeutics in cancer. I am a board-certified hematologist-oncologist and informaticist with specialized training in basic science, health services, and translational research. My clinical background in oncology and PhD training in Biomedical Informatics position me to develop and apply data science methodologies on heterogeneous, multi-scale cancer to extract actionable knowledge that can improve outcomes in cancer. My ongoing research to develop and apply cutting-edge knowledge and skills to pioneer new robust methodologies for analyzing cancer big data is being supported by an NIH K01 Career Development Award in Biomedical Big Data Science. My research focuses on developing and applying machine learning frameworks and radiogenomic approaches for the integrative analysis of heterogeneous, multi-scale data to accelerate discoveries in cancer diagnostics and therapeutics. Projects include prediction modeliI am an Assistant Professor of Medicine (Oncology) and practicing oncologist at the Stanford Cancer Center with background in biomedical informatics. ng of survival and treatment response, biomarker discovery, cancer subtype discovery, and identification of new therapeutic targets.

Footer Links:

Stanford Medicine Resources: